Aspirin Market to Grow Steadily with Rising Demand for Pain Management and Cardiovascular Therapies
Aspirin market is driven by the increasing prevalence of cardiovascular diseases, chronic pain conditions, fever, and inflammatory disorders across the globe. Growing adoption of aspirin tablets, capsules, and intravenous formulations for pain relief, thrombosis prevention, and anti-inflammatory treatments is significantly supporting market growth. In addition, rising demand for combination drug products and expanding access to hospital, retail, and online pharmacies are further accelerating the adoption of aspirin-based therapies worldwide.
Browse the full report description of “Aspirin Market Size, Share & Trends Analysis Report by Route of Administration (Oral, Rectal, Parenteral), by Dosage Form (Tablets, Intravenous Injections, Capsules, and Others), by Applications (Pain, Deep Vein Thrombosis, Fever, and Inflammation and Others), by Product Type (Alone, Combination Products), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Forecast Period (2025-2035)” at https://www.omrglobal.com/industry-reports/aspirin-market
Aspire Biopharma Holdings Secured Development Agreement with Microsize for Sublingual Aspirin Formulation – 2026
In January 2026, Aspire Biopharma Holdings entered into a development and manufacturing agreement with Microsize to support the advancement of its investigational sublingual aspirin powder product intended for emergency cardiac treatment applications. The collaboration focuses on advanced particle engineering, formulation optimization, and scalable manufacturing processes designed to improve rapid drug absorption and therapeutic effectiveness. Aspire Biopharma stated that the partnership would also support future NDA submission activities and regulatory development efforts aimed at commercializing fast-acting aspirin solutions for cardiovascular emergencies and acute pain management applications.
Bayer Launched Aspirina Brand in the United States Targeting Hispanic Consumers – 2025
In September 2025, Bayer introduced its Aspirina pain relief brand in the United States as part of its strategy to expand accessibility among Hispanic consumers already familiar with the brand throughout Latin America. The launch strengthens Bayer’s over-the-counter aspirin portfolio in North America while addressing increasing demand for culturally recognized healthcare and pain relief products. The company stated that expanding the Aspirina brand would help improve consumer engagement within Hispanic communities while supporting broader growth opportunities in the OTC analgesics and cardiovascular care market.
Aspire Biopharma Holdings Announced Progress in FDA Development Pathway for Sublingual Aspirin – 2025
In February 2025, Aspire Biopharma Holdings announced the completion of feasibility studies for its fast-acting sublingual aspirin formulation and outlined plans for future interactions with the U.S. Food and Drug Administration (FDA) along with additional clinical trial activities. The company stated that the investigational aspirin product is being developed to provide rapid drug absorption and faster therapeutic response for cardiovascular emergencies and pain management applications. Aspire Biopharma further noted that the ongoing regulatory and clinical development efforts are intended to position the product as an innovative treatment option within the emergency care and OTC aspirin market.
About OMR Global
OMR Global is a market intelligence and strategic consulting firm specializing in growth advisory, competitive intelligence, and AI-enabled business research across global B2B industries.
The company supports enterprises, investors, and technology providers with actionable insights for market entry, investment analysis, procurement strategy, commercialization, and business expansion. OMR Global combines industry expertise, primary research, analytics, and digital intelligence tools to help organizations navigate evolving market landscapes and identify growth opportunities.
OMR Digital Offerings
- Pulse Intelligence Platform – AI-powered market intelligence suite designed to deliver analyst-grade insights faster and more efficiently. Built on 12+ years of research expertise and enhanced with AI-driven analytics, Pulse helps organizations transform large volumes of market and company data into actionable intelligence within hours instead of weeks. Trusted by Fortune 500 enterprises, global investment banks, strategy consultancies, and PE & VC firms, Pulse supports strategic decision-making across investment evaluation, competitive benchmarking, AI readiness, and market positioning.
Other Offerings
- Lead Generation – Verified B2B prospect data, ICP targeting, and intent-based sales intelligence
- RFx Support – End-to-end RFP, RFI, and RFQ support with vendor benchmarking and evaluation frameworks
OMR Global delivers data-driven intelligence solutions designed to support strategic decision-making, operational efficiency, and long-term business growth.
To find out more, visit www.omrglobal.com
Contact:
Mr. Anurag Tiwari
305-308, Commerce House, Janjeerwala Square,
Indore, Madhya Pradesh 452001
India
+91-780-304-0404